Effects of a 12-Month Treatment with Glucagon-like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Oxidant and Antioxidant Biomarkers in Patients with Type 2 Diabetes

• Main Authors: Vaia Lambadiari (Author), John Thymis (Author), Dimitris Kouretas (Author), Zoi Skaperda (Author), Fotios Tekos (Author), Foteini Kousathana (Author), Aikaterini Kountouri (Author), Konstantinos Balampanis (Author), John Parissis (Author), Ioanna Andreadou (Author), Maria Tsoumani (Author), Christina Chania (Author), Konstantinos Katogiannis (Author), George Dimitriadis (Author), Aristotelis Bamias (Author), Ignatios Ikonomidis (Author)
• Format: Book
• Published: MDPI AG, 2021-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Imbalance between oxidative stress burden and antioxidant capacity is implicated in the course of atherosclerosis among type 2 diabetic patients. We addressed the effects of insulin, glucagon-like peptide-1 receptor agonists (GLP1-RA), sodium-glucose cotransporter-2 inhibitors (SGLT-2i), and their c...